|
Jul 25
|
Biotech Is Booming, and This Undervalued REIT Stands to Gain
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 25
|
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jul 25
|
REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?
|
|
Jul 25
|
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
|
|
Jul 22
|
Rivian, Wayfair, and 7 More Stocks That Could Join the Meme Trade
|
|
Jul 21
|
BizTrip.AI Launches Agentic AI Assistant to Revolutionize Corporate Travel Booking and Management
|
|
Jul 18
|
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
|
|
Jul 18
|
How IBM and Moderna’s partnership could lead to an explosion in drug development
|
|
Jul 17
|
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine.
|
|
Jul 16
|
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)
|
|
Jul 14
|
JPMorgan reveals 9 stocks with major problems
|
|
Jul 14
|
Why Moderna (MRNA) Stock Is Falling Today
|
|
Jul 14
|
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults
|
|
Jul 14
|
What to Expect From Moderna's Next Quarterly Earnings Report
|
|
Jul 14
|
GSK seeks FDA nod for expanded use of RSV vaccine in adults
|
|
Jun 30
|
Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?
|
|
Jun 30
|
Sector Update: Health Care Stocks Higher Late Afternoon
|
|
Jun 30
|
Sector Update: Health Care Stocks Advance Monday Afternoon
|
|
Jun 30
|
Moderna’s mRNA flu shot outperforms current standard at Phase III
|